
Mounjaro® (Tirzepatide) Injection is a prescription medicine used for type 2 diabetes management and, in authorised markets, weight management in eligible adults. Tirzepatide works on GIP and GLP-1 receptors to support blood-glucose control and appetite regulation.
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter supporting international supply enquiries for hospitals, pharmaceutical distributors, pharmacies and eligible importers in the USA, UK, UAE and South Africa, subject to local regulations.
Mounjaro® (Tirzepatide) Uses
Mounjaro® may be prescribed for:
Type 2 diabetes management
Blood-glucose control
Weight management in eligible adults
Supporting weight reduction alongside diet and physical activity
Treatment should always be prescribed and monitored by a qualified healthcare professional.
Mounjaro® Strengths
Depending on the market and product presentation, tirzepatide is available in strengths including:
2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg
Mounjaro® is generally administered once weekly, with the dose adjusted according to the healthcare professional's instructions.
How Does Tirzepatide Work?
Tirzepatide activates GIP and GLP-1 receptors. This helps regulate blood glucose, insulin response and appetite, which can contribute to improved diabetes control and weight reduction.
Mounjaro® Supply in USA, UK, UAE & South Africa
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical export enquiries for Mounjaro® and tirzepatide products to:
USA – supply for eligible pharmaceutical and healthcare requirements
UK – pharmaceutical supply subject to UK regulations
UAE – export coordination subject to UAE import requirements
South Africa – supply subject to local registration and import regulations
All orders should comply with applicable prescription, import, customs and pharmaceutical regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
International supply coordination
Support for hospitals and pharma distributors
Export documentation assistance
Professional order processing
International shipping coordination
Support for eligible import requirements
Possible Side Effects
Common side effects may include nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Tirzepatide may not be suitable for everyone, so patients should consult a healthcare professional before starting treatment.
FAQs
1. What is Mounjaro® Injection?
Mounjaro® is a prescription medicine containing tirzepatide, used for type 2 diabetes and, in authorised markets, weight management.
2. Is Mounjaro® used for weight loss?
Yes. Tirzepatide is authorised for weight management in eligible adults in markets where this indication is approved. It should be used with an appropriate reduced-calorie diet and increased physical activity.
3. How often is Mounjaro® administered?
Mounjaro® is administered once weekly. The appropriate dose and dose-escalation schedule must be determined by a healthcare professional.
4. What strengths are available?
Mounjaro KwikPen presentations include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, depending on market availability.
5. Can I purchase Mounjaro® without a prescription?
Mounjaro® is a prescription medicine. Purchase, dispensing and importation should follow the laws and regulatory requirements of the destination country.
6. Does Cordium Pharmaceuticals supply Mounjaro® internationally?
Cordium Pharmaceuticals Pvt Ltd handles international pharmaceutical supply enquiries and can coordinate eligible orders for destinations such as the USA, UK, UAE and South Africa, subject to applicable regulations and product availability.
7. Can hospitals and pharmaceutical distributors contact Cordium Pharmaceuticals?
Yes. Hospitals, licensed pharmaceutical distributors, pharmacies and other eligible buyers can contact Cordium Pharmaceuticals Pvt Ltd regarding international supply requirements.
Conclusion
Mounjaro® (Tirzepatide) Injection is an important prescription treatment for type 2 diabetes and, where approved, weight management. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical export and supply coordination from India for eligible buyers in the USA, UK, UAE and South Africa.
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter supporting international supply enquiries for hospitals, pharmaceutical distributors, pharmacies and eligible importers in the USA, UK, UAE and South Africa, subject to local regulations.
Mounjaro® (Tirzepatide) Uses
Mounjaro® may be prescribed for:
Type 2 diabetes management
Blood-glucose control
Weight management in eligible adults
Supporting weight reduction alongside diet and physical activity
Treatment should always be prescribed and monitored by a qualified healthcare professional.
Mounjaro® Strengths
Depending on the market and product presentation, tirzepatide is available in strengths including:
2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg
Mounjaro® is generally administered once weekly, with the dose adjusted according to the healthcare professional's instructions.
How Does Tirzepatide Work?
Tirzepatide activates GIP and GLP-1 receptors. This helps regulate blood glucose, insulin response and appetite, which can contribute to improved diabetes control and weight reduction.
Mounjaro® Supply in USA, UK, UAE & South Africa
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical export enquiries for Mounjaro® and tirzepatide products to:
USA – supply for eligible pharmaceutical and healthcare requirements
UK – pharmaceutical supply subject to UK regulations
UAE – export coordination subject to UAE import requirements
South Africa – supply subject to local registration and import regulations
All orders should comply with applicable prescription, import, customs and pharmaceutical regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
International supply coordination
Support for hospitals and pharma distributors
Export documentation assistance
Professional order processing
International shipping coordination
Support for eligible import requirements
Possible Side Effects
Common side effects may include nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Tirzepatide may not be suitable for everyone, so patients should consult a healthcare professional before starting treatment.
FAQs
1. What is Mounjaro® Injection?
Mounjaro® is a prescription medicine containing tirzepatide, used for type 2 diabetes and, in authorised markets, weight management.
2. Is Mounjaro® used for weight loss?
Yes. Tirzepatide is authorised for weight management in eligible adults in markets where this indication is approved. It should be used with an appropriate reduced-calorie diet and increased physical activity.
3. How often is Mounjaro® administered?
Mounjaro® is administered once weekly. The appropriate dose and dose-escalation schedule must be determined by a healthcare professional.
4. What strengths are available?
Mounjaro KwikPen presentations include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, depending on market availability.
5. Can I purchase Mounjaro® without a prescription?
Mounjaro® is a prescription medicine. Purchase, dispensing and importation should follow the laws and regulatory requirements of the destination country.
6. Does Cordium Pharmaceuticals supply Mounjaro® internationally?
Cordium Pharmaceuticals Pvt Ltd handles international pharmaceutical supply enquiries and can coordinate eligible orders for destinations such as the USA, UK, UAE and South Africa, subject to applicable regulations and product availability.
7. Can hospitals and pharmaceutical distributors contact Cordium Pharmaceuticals?
Yes. Hospitals, licensed pharmaceutical distributors, pharmacies and other eligible buyers can contact Cordium Pharmaceuticals Pvt Ltd regarding international supply requirements.
Conclusion
Mounjaro® (Tirzepatide) Injection is an important prescription treatment for type 2 diabetes and, where approved, weight management. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical export and supply coordination from India for eligible buyers in the USA, UK, UAE and South Africa.
Keywords







